Mounjaro approval expanded to reduce the risk of major cardiovascular events; The American Academy of Pediatrics has issued updated recommendations for RSV immunization; BTK inhibitor shows promise in ...

FDA clears Zanvastro (zilganersen) as the first disease-modifying therapy for Alexander disease following positive Phase 1-3 trial results.

The updated guidelines broaden the high-risk criteria for children aged 8 to 19 months entering their second RSV season.

Following Fast Track designation, a phase 2a trial will evaluate inhaled treprostinil (Yutrepia) as a potential first-in-class therapy for Raynaud phenomenon in systemic sclerosis.

Blood-based test identifies presence of amyloid plaques in symptomatic adults and is intended to be used in conjunction with a clinical assessment ...

HealthDay News — Silent atherosclerosis is detectable in early adulthood and increases with age, according to a study published online August 29 in the New England Journal of Medicine to coincide with ...

HealthDay News — Time-restricted eating (TRE) may help adults with type 1 diabetes (T1D) and overweight control their blood sugar, according to a study published online August 17 in Diabetes Care.

Updated recommendations are presented to help clinicians decide which medications may be effective for preventing migraine in adults in 2 reports issued by the American Academy of Neurology and ...

Proportion of women never screened for cervical cancer increased, with more pronounced increase from 2010 to 2023 ...

Predicted prevalence of birth defects lower at levels of 906 to 1131 nmol/L for postconception maternal RBC folate.

Federal health officials have launched a web page that gathers the nation’s drug overdose numbers, prevention tips and treatment resources into a single place. The US Centers for Disease Control and ...

Risk reduced for primary cardiovascular event, but no reduction seen in risk for death from any cause, dementia, or persistent physical disability ...